Contact Us

*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

Age of patient when antidepressant(s) prescribed:

What condition was this medication prescribed to treat?

What additional medications were you taking at the time?

Did patient hurt themselves during or after taking the drug?

Did patient become violent during or after taking the drug?

Was suicide attempted?

Was hospitalization or institutionalization required after taking antidepressant(s)?

Did loved one commit suicide?

If patient did attempt or commit suicide, did patient ever attempt suicide previously?

If patient did commit suicide, what was the method of suicide?

Please describe violent or suicidal behavior:

If you ever tried to stop taking Paxil and experienced withdrawal, please describe the withdrawal side effects:

Please further describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Paxil Brings Suicidal Thoughts

Jul 14, 2003 |

America's most-prescribed antidepressant may kick off suicidal thoughts and self-harm in young people, says the drug manufacturer. A recent study by GlaxoSmithKline, the British drug company that produces Paxil, has led British officials to recommend that doctors refrain from prescribing it to children under 18.

The U.S. Food and Drug Administration followed suit. Reporting that it has not completed its evaluation of the new safety data, the agency emphasized that patients should not suddenly discontinue use of the drug.

In the Glaxo study, Paxil (Seroxat in the U.K.) more than doubled emotional side effects including mood swings, crying episodes, suicidal thoughts and self-harm in children, compared to those taking a placebo. It was the first study to document such side effects of the drug, one of the commonly prescribed antidepressants called SSRIs (selective serotonin reuptake inhibitors).

The reaction of the American psychiatric community has been conspicuously muted. Richard Kadison, M.D., director of health services at Harvard University, told Blues Buster that Paxil does lead to a higher incidence of weight gain and withdrawal symptoms when compared to other SSRIs. But he has not observed a significant increase in suicidal thoughts or behaviors.

"We've probably all seen one incident of increased depression with any of the SSRIs," says Kadison, "but I don't see any reason to pick Paxil out." He and his colleagues do not use Paxil as a "first-line" drug because of withdrawal problems and weight gain, a side effect that is particularly objectionable to young adults.

Columbia University psychiatrist John Mann, M.D., an expert on suicide, calls "premature" the warning against prescribing Paxil to children. Glaxo's data are insufficient for establishing a direct relationship between Paxil and instances of emotional side effects, he contends.

The warning may backfire. "Physicians may be afraid to use medications that are potentially helpful and important in prevention of suicide," says Mann. "If that is the case, there may actually be more suicides rather than fewer."

Mann points to a decline in suicides in the US as use of SSRIs has increased four-fold, suggesting the drugs may aid suicide prevention.

Following the warning, Glaxo spokesmen were quick to note that none of the children studied succeeded in committing suicide while taking Paxil.

Related articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo